By surgical removal and postoperative radiotherapy, PUMCH defeated keloid recurrence and achieved cosmetic effects. After eight-year treating and following 1033 cases, it reported a clinical cure rate of 91.7%, leading the world in both case numbers and medical results.

Keloid is the formation of a type of benign scar, a result of an overgrown of tissue at the site of a healed skin injury. It usually occurs among young people, and at the sites of front chest, face and ears. It is often accompanied by pain, itchiness and serious infections, thus severely affecting the patient’s life and appearance. It is hard to cure, given its complicated causes, and traditional treatments, including hormone injection, isotope therapy and simple surgical removal, may have a high rate of recurrence.

Since 2004, our Department of Plastic and Cosmetic Surgery and Department of Radiotherapy developed a method of surgical removal followed by radiotherapy. Thanks to improved surgical techniques, radiation procedures and amounts, the clinical cure rate has been greatly boosted. A patient will receive 900cGy radiation one day and seven days after surgical removal, to restrain collagen formation. In eight years, 1033 cases are recorded with a clinical cure rate reaching 91.7%.